Bariatric Surgical Management of Morbid Obesity
JH · Effective Oct 1, 2015
125 active Medicare policies list E11.311, and 8 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
Showing 100 of 125
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Oct 1, 2015
JF · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
8 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E11.311 |
|---|---|---|
| ADAMTS13 Assay for Thrombotic Thrombocytopenic Purpura (TTP) | Oct 26, 2023 | Covered |
| Artificial Retina and Artificial Iris | Oct 17, 2023 | Covered |
| Fluocinolone Acetonide Intra-vitreal Implant (Retisert, Yutiq and Iluvien) | Jan 5, 2024 | Covered |
| Optic Nerve and Retinal Imaging Methods | May 17, 2023 | Covered |
| Retinopathy Telescreening Systems | Aug 10, 2023 | Covered |
| Vitrectomy | Jun 22, 2023 | Covered |
J5 · Effective Oct 13, 2024
J8 · Effective Oct 13, 2024
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Jan 30, 2022
J9 · Effective Feb 2, 2018
JH · Effective Jan 25, 2018
JL · Effective Jan 25, 2018
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Nov 2, 2020
J9 · Effective Oct 11, 2020
J6 · Effective Dec 1, 2020
JK · Effective Dec 1, 2020
JE · Effective Nov 2, 2020
JF · Effective Nov 2, 2020
JH · Effective Oct 11, 2020
JL · Effective Oct 11, 2020
JJ · Effective Apr 18, 2021
JM · Effective Apr 18, 2021
J5 · Effective Oct 11, 2020
J8 · Effective Oct 11, 2020
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JJ · Effective Jan 22, 2023
JM · Effective Jan 22, 2023
J15 · Effective Mar 19, 2018
J15 · Effective Aug 10, 2026
JE · Effective Aug 10, 2026
JF · Effective Aug 10, 2026
JJ · Effective Aug 10, 2026
JM · Effective Aug 10, 2026
J5 · Effective Aug 10, 2026
J8 · Effective Aug 10, 2026
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J15 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
JH · Effective Oct 1, 2015
JL · Effective Oct 1, 2015
JJ · Effective Jan 29, 2018
JM · Effective Jan 29, 2018
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
J5 · Effective Oct 1, 2015
J8 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2015
J6 · Effective Mar 16, 2017
JK · Effective Mar 16, 2017
J5 · Effective Jul 17, 2017
J8 · Effective Jul 17, 2017
J9 · Effective Oct 1, 2015
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
National · Effective Jan 1, 2026
JL · Effective Jan 1, 2026
J6 · Effective Jan 1, 2026
National · Effective Oct 1, 2025
National · Effective Jan 1, 2026
National · Effective Oct 1, 2025
J6 · Effective Oct 1, 2025
J5 · Effective Nov 14, 2024
JL · Effective Oct 1, 2024
J9 · Effective Oct 1, 2024
National · Effective Nov 16, 2023
National · Effective Nov 7, 2019
J5 · Effective Oct 1, 2025
National · Effective Jan 1, 2025
National · Effective Apr 17, 2025
National · Effective Oct 1, 2024
JL · Effective Apr 1, 2025
J6 · Effective Apr 1, 2025
National · Effective Oct 9, 2025
National · Effective Oct 23, 2025
J9 · Effective Apr 1, 2025
J5 · Effective Apr 1, 2025
National · Effective Apr 1, 2025
National · Effective Nov 6, 2025
| Policy | Effective | Status of E11.311 |
|---|---|---|
| Posterior Segment Optical Coherence Tomography | Jan 6, 2026 | Covered |
| Policy | Effective | Status of E11.311 |
|---|---|---|
| Susvimo (Ranibizumab Injection) | Aug 1, 2026 | Covered |